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Abstract
MCM-BP was discovered as a protein that co-purified from human cells with MCM proteins 3 through 7; results which were
recapitulated in frogs, yeast and plants. Evidence in all of these organisms supports an important role for MCM-BP in DNA
replication, including contributions to MCM complex unloading. However the mechanisms by which MCM-BP functions and
associates with MCM complexes are not well understood. Here we show that human MCM-BP is capable of interacting with
individual MCM proteins 2 through 7 when co-expressed in insect cells and can greatly increase the recovery of some
recombinant MCM proteins. Glycerol gradient sedimentation analysis indicated that MCM-BP interacts most strongly with
MCM4 and MCM7. Similar gradient analyses of human cell lysates showed that only a small amount of MCM-BP overlapped
with the migration of MCM complexes and that MCM complexes were disrupted by exogenous MCM-BP. In addition, large
complexes containing MCM-BP and MCM proteins were detected at mid to late S phase, suggesting that the formation of
specific MCM-BP complexes is cell cycle regulated. We also identified an interaction between MCM-BP and the Dbf4
regulatory component of the DDK kinase in both yeast 2-hybrid and insect cell co-expression assays, and this interaction
was verified by co-immunoprecipitation of endogenous proteins from human cells. In vitro kinase assays showed that MCM-
BP was not a substrate for DDK but could inhibit DDK phosphorylation of MCM4,6,7 within MCM4,6,7 or MCM2-7
complexes, with little effect on DDK phosphorylation of MCM2. Since DDK is known to activate DNA replication through
phosphorylation of these MCM proteins, our results suggest that MCM-BP may affect DNA replication in part by regulating
MCM phosphorylation by DDK.
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Introduction
The initiation of DNA replication in all eukaryotes involves the
assembly of pre-replicative complexes (pre-RC) at the origins of
replication in the G1 phase of the cell cycle, followed by the
activation of the pre-RC at the onset of S phase. A critical
component of the pre-RC is the minichromosome maintenance
(MCM) complex, which is comprised of MCM proteins 2 through
7 that form a hexameric ring [1]. Double hexamers of the MCM
complex are loaded onto each origin by the action of Cdc6 and
Cdt1 and, upon entry into S phase, this complex is activated by
phosphorylation by the S-phase specific kinase DDK (Dbf4/Drf1-
dependent kinase) (reviewed in [2,3]). DDK is comprised of the
cdc7 kinase and either Dbf4 or Drf1 regulatory subunits. DDK
phosphorylates MCM2, MCM4 and MCM6 and triggers the
recruitment of Cdc45 and GINS to form the Cdc45, MCM, GINS
(CMG) complex that functions as the replicative helicase
[4,5,6,7,8,9,10].
MCM2-7 are members of the AAA+ ATPase family of proteins
and can hydrolyse ATP when combined into particular MCM
dimer pairs or larger complexes [1,11,12,13]. MCM4,6,7 and
MCM4,7 can form stable hexamers that have DNA helicase
activity [13,14,15], although MCM2-7 hexamers are thought to be
the active form of the helicase in the context of the CMG complex
[4,11]. MCM proteins are present in cells at levels considerably
above what is needed to unwind DNA at replication forks,
suggesting that they can play additional roles [1]. Indeed, excess
chromatin-associated MCM complexes have been found to be
important under conditions of replication stress, where they
activate dormant origins to ensure that DNA replication continues
when replication forks stall [16,17]. In addition, some MCM
subunits appear to have additional functions that are independent
from DNA replication [18,19,20].
In efforts to more completely understand the functions and
regulation of MCM proteins, human MCM6 and MCM7 subunits
were subjected to in vivo tandem affinity purification (TAP) tagging,
revealing that these proteins not only interact with the other MCM
proteins, but also co-purify with a previously unstudied protein
that we named MCM-BP [21]. MCM-BP is conserved in most
eukaryotes (except budding yeast and C. elegans) and has only
limited homology to MCM proteins. TAP-tagging or immuno-
precipitation of MCM-BP from human cells, Xenopus egg extracts
and Schizosaccharomyces pombe recovered MCM 3 through 7 but not
MCM2 [21,22,23,24]. Conversely TAP-tagging of MCM2 in
human cells recovered MCM3 through 7 but not MCM-BP,
suggesting that alternative MCM complexes exist that contain
either MCM-BP or MCM2. However, MCM-BP can also interact
with some MCM proteins individually as interactions between
Xenopus MCM-BP and MCM7 and between Arabidopsis thaliana
MCM-BP (ETG1) and MCM5 have been reported [22,25].
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subcomplex but did not inhibit the in vitro helicase activity of this
complex [21].
Like MCM proteins, MCM-BP is a nuclear protein found in
both chromatin-associated and soluble forms. In human cells, a
proportion of MCM-BP is chromatin associated through G1 and
S, with preferential origin localization at G1/S, then dissociates
from the DNA at late G2 or early M, resembling the pattern of
chromatin association of the MCM complex [21]. In S. pombe,
MCM-BP is encoded by an essential gene (mcb1) [23]. Deletion of
pombe mcb1 resulted in gradual cell cycle arrest and a cdc
phenotype, whereas Mcb1 overexpression induced DNA damage
and Chk1 activation [23]. Similarly Mcb1 inactivation in S. pombe
or MCM-BP depletion in human cells resulted in increased DNA
damage and G2 checkpoint activation [24,26]. In human cells,
MCM-BP depletion also leads to centrosome amplification and
abnormal nuclear morphology, which may be due to the G2
checkpoint activation [26]. The MCM-BP homologue in A.
thaliana (ETG1) was identified as an E2F target and loss of ETG1
was found to reduce DNA replication, activate the G2 checkpoint
and reduce sister chromosome cohesion [25,27]. All of these
observations point to an important role of MCM-BP in DNA
replication.
One of the roles of MCM-BP appears to be in unloading the
MCM complex from chromatin after DNA synthesis as suggested
by studies in Xenopus egg extracts, where depletion of MCM-BP
from the extracts reduced the dissociation of MCMs from the
chromatin at the end of S phase [22]. However, MCM-BP
depletion in human cells not only increased the levels of
chromatin-associated MCMs at the end of S phase, but resulted
in a similar increase in the soluble levels of MCMs throughout S
phase [22,26], suggesting that MCM-BP makes multiple contri-
butions to DNA replication. A major difference between human
cells and the Xenopus extract system is that MCM-BP only enters
the Xenopus nuclei in mid S phase, whereas MCM-BP in human
cells is largely nuclear throughout the cell cycle, where it may
affect other functions of the MCM complex proteins.
While TAP-tagging and endogenous immunoprecipitations
performed in human cells suggest that MCM-BP can form a
hexameric complex with MCM3-7, it is not clear how MCM-BP
interacts with this complex nor has it been determined whether
human MCM-BP can interact with any individual MCM subunits.
In addition, while recruitment of DDK to the MCM2-7 complex is
known to be important for DNA replication, it is not known
whether MCM-BP or MCM-BP-containing MCM complexes
associate with this kinase. Here we examine the associations of
MCM-BP with individual MCM complex proteins and DDK. We
show that MCM-BP is capable of interacting with any individual
MCM protein but interacts most strongly with MCM4 and
MCM7. In addition, we show that MCMBP and MCM proteins
form part of a large complex that forms at mid to late S phase.
Finally, we identify an interaction between MCM-BP and the
Dbf4 subunit of DDK and show that MCM-BP can decrease
MCM phosphorylation by DDK in vitro.
Results
MCM-BP Can Interact with any Individual MCM Subunit
We examined the ability of MCM-BP to interact with MCM
proteins by co-expressing MCM-BP with individual MCM
proteins in insect cells. To this end, insect cells were infected with
a baculovirus expressing affinity tagged MCM4, MCM5, MCM6
or MCM7 (Strep-MCM4, FLAG-MCM5, HA-MCM6, FLAG-
MCM7) with or without a second baculovirus expressing untagged
MCM-BP. Tagged MCM proteins were then recovered on the
appropriate affinity resin (Strep T actin for MCM4, anti-HA for
MCM6 and anti-FLAG for MCM5 and 7) and recovery of the
MCM protein and MCM-BP was assessed by Coomassie staining
(Figure 1A). Each MCM protein recovered MCM-BP, whereas
MCM-BP was not recovered on the affinity resin in the absence of
the MCM protein. In each case, MCM-BP recovery was
proportional to the amount of MCM protein recovered suggesting
a stoichiometric interaction. We also found that the presence of
MCM-BP dramatically increased the recovery of MCMs 4, 5 and
7, also supporting an interaction of MCM-BP with these proteins.
The increased recovery of these MCM proteins in the presence of
MCM-BP may be due to the increased solubility of MCMs 4, 5
and 7 when expressed in the presence of MCM-BP. As shown in
Figure 1B, these MCM protein are largely insoluble when
expressed in insect cells on their own, but the amount of
MCM4, 5 or 7 in the soluble fraction is increased when co-
expressed with MCM-BP (most obviously for MCM7). On the
other hand, MCM6 is largely soluble on its own which may be
why its recovery is not increased by MCM-BP, even though these
proteins can interact.
In the experiments in Figure 1A, we noticed that the MCM
proteins expressed in the absence of human MCM-BP, often
recovered a small amount of protein that ran at a size consistent
with MCM-BP, suggesting that it might be the endogenous insect
MCM-BP. To investigate this further, we repeated the affinity
purification experiments with MCM 4, 6 and 7 in the presence
and absence of MCM-BP and performed Western blots on the
recovered proteins with MCM-BP antibody (Figure 1C). All three
of these MCM proteins recovered a band the size of MCM-BP in
the absence of the MCM-BP baculovirus, and the Western blot
confirmed that this band was likely endogenous insect MCM-BP
since it was recognized by anti-MCM-BP antibody. This suggests
that interactions of these MCM proteins with MCM-BP do not
require high levels of MCM-BP and can occur with the
endogenous insect MCM-BP.
MCM2 is the only MCM complex protein that is not recovered
with MCM-BP isolated from human cells. This could either mean
that MCM-BP binds the MCM3-7 complex or that MCM-BP
forms dimer pairs with MCM3 through 7 and is unable to
dimerize with MCM2. To differentiate between these possibilities
we tested whether MCM-BP could bind MCM2 in pulldown
assays in insect cells. When Strep-tagged MCM2 was co-expressed
in insect cells with untagged MCM-BP, MCM-BP was recovered
with MCM2 on the Strep-T actin resin, but much less MCM-BP
was recovered on the resin in the absence of MCM2 (not
detectable by Coomassie staining), indicating that the two proteins
can interact (Figure 1D; compare lanes 1 and 3). However, unlike
the interaction with MCM4, 5 and 7, the presence of MCM-BP
did not increase the recovery (Figure 1D; compare lanes 2 and 3)
or solubility (Figure 1B) of MCM2. Also MCM2 did not recover
detectable amounts of endogenous insect MCM-BP (Figure 1D,
lane 2), suggesting that the MCM2-MCM-BP interaction requires
higher levels of proteins and hence is a lower affinity interaction
than MCM-BP interactions with the other MCM proteins.
Finally, we generated baculoviruses expressing each MCM
protein with a 6-His-tag and expressed these proteins with and
without MCM-BP (with a Strep tag but lacking a His-tag) in insect
cells in order to compare MCM recovery using the same affinity
resin (Figure 1E). The results confirmed that all MCM proteins
interact to some degree with MCM-BP and that the presence of
MCM-BP increases the recovery of all MCMs except MCM2 and
MCM6.
MCM-BP Interactions with MCM and Dbf4 Proteins
PLoS ONE | www.plosone.org 2 April 2012 | Volume 7 | Issue 4 | e35931Figure 1. MCM-BP interacts with individual MCM proteins. A. Affinity tagged MCM4, 5, 6 or 7 (M4, M5, M6, M7) were expressed from
baculoviruses in the presence (+BP) or absence of a baculovirus expressing MCM-BP. Cell lysates were then incubated with the appropriate affinity
resin and bound protein were eluted by boiling in SDS buffer. Cells infected only with the MCM-BP baculovirus (BP lanes) were included as a negative
control for each resin. A Coomassie stained gel of the eluted proteins is shown. B. The indicated MCM protein was expressed in insect cells with or
without MCM-BP. Cell lysates were clarified by centrifugation and equal fractions of the soluble (S) and pelleted proteins (P) were analysed by SDS-
PAGE and Coomassie staining. C. Affinity tagged MCM4, 6 or 7 were expressed with or without MCM-BP and recovered on affinity resin as in A. The
top panel shows the Coomassie stained gel of the eluted proteins. The same samples were also immunoblotted using anti-MCM-BP antiserum
(bottom panel). Purified MCM-BP (200 ng) was loaded as a marker in lane 1 (BP-M). D. Strep-tagged MCM2 was expressed in insect cells with or
without MCM-BP, recovered on Strep-T actin resin and processed as in C. MCM-BP expressed on its own was also incubated with Strep-T actin resin to
establish the level of nonspecific interaction with the resin (lane 1). Purified MCM-BP (1 mg) was loaded as a marker in lane 4 (BP-M). E. The indicated
6-His-tagged MCM protein was expressed with or without MCM-BP (as indicated) and recovered on Ni-NTA resin. In lane 1, MCM-BP was expressed on
its own to determine the level of nonspecific binding to the Ni-NTA resin. A Coomassie stained gel of the eluted proteins is shown.
doi:10.1371/journal.pone.0035931.g001
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The pull-down assays performed above can detect relatively
weak or transient protein interactions. To get a better sense of the
strength of the MCM-BP interaction with individual MCM
proteins, MCM-BP-MCM protein pairs were expressed in insect
cells and isolated by virtue of the affinity tag on the MCM protein
or a His-tag on MCM-BP (for MCM3 interaction only where
MCM3 has no tag). The recovered proteins were then subjected to
glycerol gradient sedimentation, which only detects protein
interactions that are stable enough to remain intact during a
16 hour spin through the glycerol gradient. MCM-BP on its own
migrates at the top of the gradient, peaking at fractions 2 to 3
(Figure 2, top panel), and a stable interaction with any MCM
protein would be expected to shift this peak towards the bottom of
the gradient due to its larger size. When the MCM-BP-MCM
pairs were analysed on identical gradients, only MCM4 and
MCM7 pairs caused a significant shift in the migration of the
MCM-BP peak, such that the bulk of the MCM-BP migrated in
fractions 4 to 6 and corresponded closely to the migration of
MCM4 and MCM7. This indicates that MCM-BP formed a stable
complex with MCM4 and MCM7. Other MCM proteins caused
the broadening of the MCM-BP peak towards the bottom of the
gradient to various degrees with a significant proportion of MCM-
BP remaining at fractions 2–3. This is suggestive of interactions
that were dissociating during the course of the gradient. Therefore
this assay indicates that MCM-BP interacts most strongly with
MCM4 and MCM7.
Effects of Salt and Detergent on MCM-BP-MCM
Interactions
We further investigated the strength of the interaction of MCM-
BP with MCM4 and MCM7, by co-expressing the proteins in
insect cells and isolating the MCM protein on affinity resin under
various conditions. As shown in Figure 3A and B, MCM-BP was
efficiently recovered with MCM4 or MCM7 under a variety of
conditions including NaCl concentrations up to 0.75 M and
deoxycholate up to 0.5% (with 150 mM NaCl). Therefore these
interactions are extremely stable and are particularly resistant to
high salt concentrations. We then performed similar interaction
assays expressing His-tagged MCM-BP with the other MCM
proteins (untagged) from insect cells and isolating MCM-BP on
nickel resin under the same conditions as above (Figure 3C). The
ratio of the two recovered proteins in the 0.5% deoxycholate and
0.75M NaCl conditions was determined and is shown relative to
the ratio in the 0.15 M NaCl condition (set to 1; Figure 3D).
MCM-BP interactions with each of the MCM proteins were
observed under all of the conditions tested, although the recovery
of MCM 2, 3 and 5 with MCM-BP was noticeably decreased in
0.5% deoxycholate and the recovery of MCM2 was also decreased
in 0.75M NaCl concentrations. These results are in keeping with
the glycerol gradient analyses that MCM-BP interactions with
MCM 2, 3 and 5 are less stable than with MCM 4 and 7.
Finally, we also sought conditions that could disrupt the stable
interactions of MCM-BP with MCM4 and 7. To this end, His-
tagged MCM4 or MCM7 was coexpressed with untagged MCM-
BP in insect cells, then cells were lysed and the MCM-MCM-BP
complexes were recovered on nickel resin. Incubation of the resin
with various buffers showed that MCM-BP was released from
MCM4 or MCM7 when small amounts of CHAPS (0.1–0.2%)
were included in the wash buffer (Figure 3E), showing the
sensitivity of the MCM-BP-MCM interactions to this nondenatur-
ing zwitterionic detergent.
Analysis of MCM-BP and MCM Complexes in Human Cells
While previous studies suggest that MCM-BP can form
complexes with MCM proteins [21], it is not clear how frequently
and under what circumstances these complexes form in cells. We
examined the state of MCM-BP complexes in human cells by
performing glycerol gradient sedimentation analysis of log-phase
HeLa cell extracts and immunoblotting for MCM-BP and MCM
proteins (Figure 4A, left panel). We found that the MCM proteins
co-migrate in the gradient at a size consistent with a hexameric
complex and that a proportion of the MCM-BP also overlapped
with this peak, suggesting that some of the MCM complexes may
Figure 2. Glycerol gradient sedimentation analyses of MCM-
MCM-BP pairs. Affinity tagged MCM proteins were co-expressed with
nontagged MCM-BP in insect cells then recovered on and eluted from
the appropriate affinity resin as described in Materials and Methods.
His-tagged MCM-BP was also expressed on its own and recovered on
Ni-NTA resin (top panel). 150–200 mg of protein was then subjected to
centrifugation through a glycerol gradient for 16 hours. 24 500 ml
fractions were collected from the top of the gradient and 35 ml samples
of each were analysed by SDS-PAGE and silver staining. Only the top 12
fractions are shown since they contained all of the protein. The peak
positions of molecular weight markers aldolase (158 kDa), catalase
(232 kDa) and thyroglobulin (669 kDa) are indicated at the top of the
gels.
doi:10.1371/journal.pone.0035931.g002
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peaked at a higher position in the gradient suggesting that it was
not MCM-associated. Since Xenopus MCM-BP has been found to
be able to dissociate MCM complexes [22], we also examined
whether the addition of excess exogenous MCM-BP to the cell
lysate affected the migration of the MCM proteins (Figure 4A,
right panel). The addition of MCM-BP resulted in dissociation of
the MCM complex such that the MCM proteins now largely
migrated at positions indicative of individual proteins or smaller
complexes. Note that the right MCM-BP panel is a lighter
exposure than the left MCM-BP panels due to the higher levels of
MCM-BP present.
Since MCM complexes and MCM-BP function as DNA
replication proteins in S phase, similar experiments as above were
performed with HeLa cells that were synchronized at the G1/S
boundary (using a double thymidine block) and released into S
phase. The results at the 2 hour (early S) time point (Figure 4B, left
panel) were very similar to those in log-phase cells, except that there
maybelessMCM-BPatthepositionofthelargeMCMcomplex.At
mid to late S-phase (4 and 6 hour time points; Figure 4C and 4D,
left panels), a small fraction of the MCM-BP formed a second peak
(at fraction 14) that overlapped with the MCM hexamer peak. The
addition of excess MCM-BP to the extracts from any of these time
pointsresulted indissociationoftheMCMhexamers, butinthe mid
to late S extracts, a small amount of the MCMs were still detected in
a large complex that also contained MCM-BP, migrating at
fractions 13–15 (Figure 4B–D, right panels). The formation of this
large MCM-BP-containing complex has been seen in multiple
experiments. To further determine if MCM-BP and MCM proteins
were present in the same large complex in late S, MCM-BP was
immunoprecipitated from fraction14inFigure4Dand the recovery
of MCM proteins was examined. MCM2 to 7 were all found to co-
immunoprecipitate with MCM-BP indicating that they are part of
the same complex. For comparison, we performed the same
immunoprecipitation from fraction 15, which has little MCM-BP.
As expected less MCM-BP immunoprecipitated from this fraction
and the recovery of each MCM protein also decreased. The results
suggest that, while the majority of the MCM-BP is not normally
present in MCM complexes, some of the MCM-BP is associated
withlarge MCM complexes at mid to late S. The data also indicates
that human MCM-BP, like Xenopus MCM-BP, has the ability to
disrupt MCM hexamers.
MCM-BP Interacts with Dbf4
Interactions of the MCM2-7 complex with DDK are critical for
DNA replication and can be detected by yeast 2-hybrid assays
performed with MCM2, 3, 4 and 7 subunits and the Dbf4
Figure 3. Effect of salt and detergent on MCM-BP interactions
with MCM proteins. A and B. Strep-tagged MCM4 (A) or FLAG-tagged
MCM7 (B) were expressed in insect cells with or without untagged
MCM-BP then recovered from cell lysates on Strep-T actin (A) or anti-
FLAG (B) resin. Coomassie stained gels are shown. The salt and
deoxycholate (Deoxy) concentrations in the lysis buffer are indicated.
Samples containing 0.1% and 0.5% deoxycholate also contain 150 mM
NaCl. C. Untagged MCM2, MCM3, MCM5, or MCM6 were expressed in
insect cells with and without His-tagged MCM-BP then cells were lysed
in the same buffers as in A and B as indicated. Cell lysates were then
incubated with nickel resin and bound proteins eluted with 250 mM
imidazole. Lane 9 is a negative control in which His-MCM-BP was
expressed on its own. D. The ratio of the recovered proteins
(untagged:tagged protein) in A–C was determined using ImageQuant
quantification of the protein bands and is shown relative to the ratio
seen for the 0.15 M NaCl condition (set to 1). E. His-tagged MCM4 or
MCM7 was expressed with untagged MCM-BP in insect cells. Cells were
lysed in lysis buffer containing 150 mM NaCl (no deoxycholate) and
lysates were incubated with nickel resin. After washing, the resin was
incubated in buffer containing 0, 0.1% or 0.2% CHAPS, or boiled in 2%
SDS sample buffer to show the proteins initially bound to the resin.
doi:10.1371/journal.pone.0035931.g003
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interacts with MCM proteins and can associate with cellular
origins at G1/S (when DDK is active), we wanted to determine if
MCM-BP could interact with Dbf4. We tested this initially using
yeast 2-hybrid assays in which MCM-BP fused to the LexA DNA
binding domain must interact with a target protein fused to an
activation domain in order to drive expression of a histidine gene
under control of LexA binding sites, enabling the yeast to grow on
plates lacking histidine. First we showed that MCM-BP could
mediate the expected interactions with MCM proteins in the 2-
hybrid system, as interactions with MCM4 and MCM7 were
readily detected by the vigorous growth of the yeast on plates
lacking histidine and containing 2 mM aminotriazole, which was
not seen when MCM-BP was expressed with the activation
domain alone (Figure 5A). We then used the same system to test
MCM-BP binding to Dbf4 and another unrelated kinase, Plk1. As
shown in Figure 5B, no interaction of MCM-BP with Plk1 was
detected, however MCM-BP was found to bind Dbf4, resulting in
growth of the yeast on the plates lacking histidine to an extent
slightly less than that seen with MCM-BP and MCM7.
We also tested the ability of MCM-BP and Dbf4 to interact
when co-expressed in insect cells. To this end, insect cells were
infected with a baculovirus expressing untagged MCM-BP or His-
tagged MCM-BP with or without a baculovirus expressing FLAG-
tagged Dbf4, then proteins were recovered on anti-FLAG resin
(Figure 6A). In the presence of Dbf4, both version of MCM-BP
were recovered on the resin, as observed by both Coomassie
staining (Figure 6A., top panel) and Western blotting for MCM-BP
(bottom panel), but very little MCM-BP associated with the resin
in the absence of Dbf4 (only detected by Western blotting). Note
that a background band the size of His-MCM-BP is also recovered
with Dbf4, even when it is expressed in the absence of MCM-BP
(seen in lanes 1 and 5, top panel) but this band is not recognized by
the MCM-BP antibody. Therefore the results indicate that MCM-
BP can interact with Dbf4 in this system.
Finally we asked whether an interaction between endogenous
MCM-BP and Dbf4 could be detected in human cells, by
immunoprecipitating MCM-BP from HeLa cells and blotting for
Dbf4. As shown in Figure 6B, Dbf4 was efficiently recovered with
MCM-BP but was not detected when negative control IgG was
used. Consistent with our previous findings [21], MCM4 but not
Figure 4. Analysis of MCM and MCM-BP complexes in human cell lysates. A. Cell lysates from log-phase HeLa cells were subjected to
glycerol gradient sedimentation and equal volume fractions were collected from the top of the gradient. An equal volume of each fraction was
analysed by Western blotting using antibodies against the indicated MCM protein or MCM-BP (BP; left panels). The same samples were also analysed
after the addition of purified MCM-BP to the lysate (right panels). Note that the MCM-BP blots on the right are exposed for shorter times than those
on the left due to the higher amounts of MCM-BP. The peak positions of molecular weight markers aldolase (158 kDa), catalase (232 kDa) and
thyroglobulin (669 kDa) are indicated at the top of the gels (which also apply to B–D). The DNA profile as determined by flow cytometry is shown on
the right, where G1 cells are shown in dark grey, S cells are shown in black and G2/M cells are shown in light grey. B–D. HeLa cells blocked at the G1/S
boundary with double thymidine treatment were released into S phase for 2 (B), 4 (C) or 6 (D) hours, then cell lysates were prepared and analysed as
in A. E. MCM-BP was immunoprecipitated from fractions 14 (F14) and 15 (F15) in D and immunoblots were performed for MCM-BP and each of the
MCM proteins.
doi:10.1371/journal.pone.0035931.g004
Figure 5. Yeast 2-hybrid assays of MCM-BP interactions. MCM-
BP fused to the LexA DNA binding domain was expressed in yeast
containing a histidine gene under LexA control, along with the
indicated proteins expressed as activation domain fusions from pACTII.
The empty pACTII plasmid was also expressed with MCM-BP as a
negative control. Ten-fold serial dilutions of the yeast cultures were
spotted on plates that select for the two expression plasmids with (right
panels) or without (left panels) selection for histidine expression.
doi:10.1371/journal.pone.0035931.g005
Figure 6. Interactions of MCM-BP with Dbf4. A. Untagged (BP) or
His-tagged MCM-BP (His-BP) were expressed in insect cells with or
without FLAG-tagged Dbf4 then soluble proteins were recovered on
anti-FLAG resin. Eluted proteins are shown by Coomassie staining (top
panel) and Western blots for FLAG (middle panel) and MCM-BP (bottom
panel). B. Endogenous MCM-BP was immunoprecipitated from HeLa cell
lysates (IP:BP) followed by Western blotting for MCM-BP, Dbf4, MCM2
and MCM4. Immunoprecipitation with a negative control IgG is also
shown (IP:IgG) as is 5% of the starting lysate (Input). Note that different
exposure times were used in each Western blot to maximize protein
detection.
doi:10.1371/journal.pone.0035931.g006
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that was recovered with MCM-BP migrated slightly faster than the
main Dbf4 band in the lysate and this shift in migration has also
been reported for Dbf4 immunoprecipitated with Cdc7 from
human cells [30].
MCM-BP is not a DDK Substrate but Inhibits MCM
Phosphorylation by DDK
Most of the MCM proteins that interact with Dbf4 are
substrates for DDK. Therefore we tested whether MCM-BP was
phosphorylated in vitro by purified DDK, generated by co-
expressing Dbf4 and Cdc7 in E.coli [31] and isolating the complex
as described in Materials and Methods. After incubation with this
kinase in the presence of c-
32P-ATP, no labelling of MCM-BP was
detected (Figure 7A, left panel, lane 2), although the purified
MCM4,6,7 complex (left panel, lane 4) and purified MCM2
(Figure 7A, right panel, lane 1 and Figure 7B, lane 2) were clearly
phosphorylated by the same kinase preparation. In addition, no
labelling of MCM4,6,7 (Figure 7A, left panel, lane 3) or MCM2
(Figure 7B, lane 1) was observed when DDK was left out of the
reaction, showing that the labelling was not due to a contaminat-
ing kinase in the MCM preparations. Therefore the results
indicate that MCM-BP is not a substrate for DDK.
We next asked whether MCM-BP might interfere with MCM
phosphorylation by DDK through its interactions with Dbf4 or
MCM proteins or both. To this end we preincubated increasing
amounts of MCM-BP with a constant amount of MCM4,6,7
(Figure 7A, left panel, lanes 5–8) or MCM2 (Figure 7B, lanes 3–6)
then performed the DDK kinase reaction as above. We found that
MCM-BP caused a titratable decrease in phosphorylation of
MCM4,6 and 7 but had only a subtle effect on phosphorylation of
MCM2. To account for any nonspecific effects of increasing
amounts of protein in the reactions, we repeated the MCM-BP
titration with MCM4,6,7 but balanced the amount of MCM-BP
added with BSA to maintain a constant amount of protein in each
reaction (Figure 7A, right panel, lanes 4–7). When the DDK
kinase assays were performed on these samples, the results were
the same as for the initial MCM-BP titration.
32P-containing
bands corresponding to MCM4 and 6 (which migrate too close
together to distinguish), MCM7 and MCM2 from each experi-
ment with MCM-BP titration were quantified and are shown in
the graph in Figure 7C. The results show that MCM-BP can limit
the phosphorylation of MCM4,6 and 7 by DDK but that MCM2
phosphorylation is not significantly affected.
Since the MCM complex that functions in DNA replication
contains all six MCM subunits, we also performed the DDK in vitro
phosphorylation assays with MCM2-7 hexamers, generated by
insect cell co-expression and purification as in Sakwe et al [21].
DDK phosphorylation of proteins in the MCM2-7 complex was
examined in the presence and absence of MCM-BP and compared
to that of MCM4,6,7 (Figure 7D). Control reactions lacking added
DDK, showed that there was a small amount of MCM
phosphorylation activity in the MCM2-7 preparation (lanes 5
and 7), however the addition of DDK greatly increased the
phosphorylation of the MCM proteins (compare lanes 5 and 6). As
seen for the MCM4,6,7 subcomplex, the presence of MCM-BP
greatly decreased the phosphorylation of MCM proteins migrating
in the region of MCM3-7 (we cannot distinguish which band is
labelled due to the close migration of these proteins; compare lanes
6 and 8). However, phosphorylation of the MCM2 band in the
MCM2-7 complex was much less affected by MCM-BP (compare
lanes 6 and 8). Quantification of the
32P in these bands followed by
subtraction of background labelling, showed that MCM-BP
decreased DDK phosphorylation of MCM3-7 proteins by 73%
and MCM2 by 17% in the context of the MCM2-7 complex
(Figure 7E).
Discussion
MCM-BP is known to make important contributions to DNA
replication presumably through its interaction with MCM
complexes, although the nature of these interactions have not
been well defined. Here we have shown that MCM-BP has some
propensity to interact with any of the MCM 2 to 7 proteins,
although it appears to interact most stably with MCM4 and
MCM7. These interactions can lead to the dissociation of MCM2-
7 hexamers in vitro and can affect the solubility or behaviour of
some individual MCM proteins. We also identified an interaction
with the Dbf4 regulatory component of the DDK kinase, known to
phosphorylate MCM proteins and to play multiple roles in DNA
replication.
Assessment of the physical interactions of MCM-BP with MCM
proteins expressed in insect cells indicated that, while MCM-BP
can interact with any individual MCM protein, it interacts most
strongly with MCM4 and MCM7. A preferential interaction with
MCM7, but not MCM4, was previously reported for Xenopus
MCM-BP. Sucrose gradient analysis of Xenopus egg extracts
identified a complex containing MCM-BP and MCM7, but not
other MCMs, suggesting preferential association of MCM-BP with
MCM7 [22]. Furthermore, the interaction between MCM-BP and
MCM7 was shown in GST pulldown assays to involve the MCM
box of MCM7 [22]. Since the MCM box is conserved in all MCM
proteins, this finding fits with our observations that MCM-BP has
some capacity to interact with all MCM proteins. The interaction
between Xenopus MCM-BP and MCM7 was also found to be stable
up to 0.8 M NaCl, consistent with our findings that MCM-BP
interactions with MCM proteins are very salt stable. This is typical
of interactions between MCM proteins which remain intact in up
to 1 M NaCl [5,32,33].
By assaying pairwise MCM protein interactions and determin-
ing those that result in ATPase activity, the order of the MCM
proteins in the hexameric ring has been determined [12,34].
Further work has suggested that a ‘gate’ exists between MCM2
and MCM5 whose state dictates the open and closed conforma-
tions of the MCM complex [35,36]. A ‘closed’ MCM 2/5 gate has
been shown to promote the helicase activity of the MCM complex
by activating the MCM4/7 motor, located 180 degrees across
from the MCM2/5 gate. Our finding that MCM-BP binds most
prominently to MCM4 and MCM7 suggests that MCM-BP may
contact the hexameric ring through these proteins across from the
gate, and further regulate helicase activity. Considerable evidence
indicates that MCM4 and MCM7 are key proteins in the MCM
complex and important targets for MCM functional regulation.
Phosphorylation of MCM4 serves as a means of regulating the
MCM complex, as MCM4 phosphorylation by cyclin A/Cdk2
inactivates the helicase activity [37,38]. MCM7 is also of particular
importance for the activity of the MCM2-7 hexamer as it
contributes to two ATPase active sites (with MCM4 and
MCM3) [12,35]. In addition, protein interactions with MCM7
are known to regulate the activity of the MCM complex. For
example, an interaction between cyclin A and MCM7 promotes S-
phase entry [39], while DNA replication is inhibited by binding of
the retinoblastoma protein to MCM7 [40]. MCM7 also appears to
have functions independent of the MCM complex, as MCM7 (but
not other MCM proteins) is important for Chk1 signalling through
its interactions with Rad17 and ATR-interacting protein (ATRIP)
[19,41]. In addition, a role for MCM7 in hypoxia was recently
identified in which MCM7 binds and induces the degradation of
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PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e35931Figure 7. MCM-BP can decrease phosphorylation by DDK but is not a substrate. A. 2 mg of MCM4,6,7 complex was pre-incubated with
increasing amount of MCM-BP (0,0.5, 1.0, 2.0 and 4.0 mg; lanes 4–8 in left panel and 3–7 in right panel) then combined with 250 ng of purified Cdc7-
Dbf4 in a reaction containing c-
32P-ATP. After 30 min, the reaction was stopped and samples were analysed by SDS-PAGE followed by
autoradiography (top panels) or Coomassie staining (bottom panels). In the right panel, BSA was added so that the total of MCM-BP plus BSA was
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dissociating the MCM complex, MCM-BP interactions with
MCM7 and MCM4 may regulate the functions of the MCM
complex as well as other roles of these proteins.
Our finding that MCM-BP can affect the solubility of some
individual MCM proteins raises the possibility that MCM-BP
could serve a chaperone-like function affecting the pool of MCM
proteins that are not assembled on chromatin. This property of
MCM-BP might also be important for promoting the dissociation
of MCM complexes. Previous studies on the Xenopus and S. pombe
versions of MCM-BP supported a role for MCM-BP in
dissociating MCM hexamers [22,23]. We have now shown that
this property is also intrinsic to human MCM-BP and that MCM
complexes from either G1 (the dominant phase in log-phase cells)
or various stages of S-phase can be disrupted by MCM-BP.
The co-purification of MCMs3-7 with MCM-BP from a variety
of organisms suggests that MCM-BP can form a hexameric
complex with these MCM proteins [21,22,23,24]. In addition,
MCM-BP can form a complex with the MCM4,6,7 core helicase
when co-expressed with them in insect cells [21]. However,
examination of the state of MCM-BP complexes by glycerol or
sucrose gradient sedimentation of cell extracts has given variable
results in different organisms. Analysis of Xenopus interphase egg
extracts detected a complex of MCM-BP and MCM7 but did not
detect MCM-BP in large MCM complexes [22]. Li et al [24]
found that pombe Mcb1 co-migrated with MCM4 and MCM6 but
the migration of other MCM proteins was not examined. Our
analysis of human cell extracts indicated that most of the MCM-
BP did not co-migrate with the MCM hexamers, nor did we detect
obvious complexes between MCM-BP and single MCM subunits.
However, a small proportion of the MCM-BP appeared as a
distinct high-molecular weight peak in mid to late S phase, that
also contained the MCM proteins. This observation may be
relevant for MCM complex unloading since previous data suggests
that MCM-BP promotes the dissociation of MCM complexes from
the chromatin in mid to late S [22]. Our results suggest that, in
human cells, higher order complexes between MCM-BP and
MCM proteins are not constitutive but may form transiently
during S phase.
Interactions between MCM proteins and DDK are known to be
important for origin activation. Since MCM-BP forms complexes
with MCM proteins and can be detected on cellular origins at G1/
S (when DDK is active) [21], we wanted to examine whether
MCM-BP interacted with the Dbf4 regulatory component of this
kinase. We found that MCM-BP interacted with Dbf4 in yeast 2-
hybrid assays and upon co-expression in insect cells, and that the
two endogenous proteins co-immunoprecipitated from human
cells. While the interaction of DDK with the MCM complex is
known to result in the phosphorylation of MCM2, MCM4 and
MCM6, an important event in origin activation [6,7,8,9,10,42,43],
we found that MCM-BP was not phosphorylated by DDK in vitro
whereas MCM2, 4, 6 and 7 were phosphorylated under the same
conditions. While MCM7 phosphorylation by DDK has not been
widely studied, budding yeast MCM7 has also been reported to be
a substrate for DDK [44]. Interestingly, we found that MCM-BP
inhibited DDK phosphorylation of the MCM4,6,7 complex in a
dose-dependent manner, suggesting that the interaction of MCM-
BP with DDK and/or the MCM4,6,7 complex interfered with
phosphorylation. Indeed we have previously shown that MCM-BP
forms a complex with MCM4,6,7 that is stable to glycerol gradient
sedimentation [21]. The finding that DDK phosphorylation of
MCM2 was less affected by MCM-BP suggests that the strong
interaction of MCM-BP with the MCM4,6,7 complex is at least
partly responsible for this inhibition, as opposed to having a direct
effect on cdc7 activity. We also confirmed these findings in
MCM2-7 hexamers, where MCM-BP had little effect on MCM2
but inhibited DDK phosphorylation of one or more of the other
MCM proteins. The ability of MCM-BP to affect DDK
phosphorylation of MCM 4 and 6 may be relevant for origin
activation where these phosphorylation events have been shown to
be important. MCM-BP was found to be preferentially associated
with the lamin B2 origin at G1/S where it could conceivably
influence DDK phosphorylation at this stage of the cell cycle [21].
In addition, DDK has been found to be important for S-phase
progression through MCM4 phosphorylation, Chk1 checkpoint
signalling and replication fork restart after a prolonged S-phase
checkpoint, raising the possibility that MCM-BP might also impact
these processes through regulation of DDK phosphorylation
[29,45,46,47,48,49,50]. Future studies on the role of the MCM-
BP/Dbf4 interaction will be important for elucidating the




Antibodies used in this report were MCM2 (Santa Cruz 9839),
MCM3 (Santa Cruz 9850), MCM4 (Santa Cruz 22779), MCM5
(Santa Cruz 165993), MCM6 (Santa Cruz 9843), MCM7 (Santa
Cruz, 22782), Dbf4 (Santa Cruz 11354) and Flag M2 (Sigma). The
antibody against MCM-BP has been described previously [21].
For Western blots, all secondary antibodies were coupled to
horseradish peroxidase (obtained from Santa Cruz Biotechnology)
and detected by ECL.
Baculoviruses
Baculoviruses expressing individual MCM proteins or MCM-
BP with N-terminal 6-histidine tags (MCM-BP, MCM3) or with 6-
His tags in combination with a triple FLAG tag (MCM5 and
MCM7) or a StrepII tag (MCM4) or a HA tag (MCM6) were
generated using the pfastBacHT system as described in Sakwe et al
[21]. Baculoviruses expressing MCM-BP with no tags or an N-
terminal StrepII-tag or Dbf4 with 6-His and FLAG tags were also
generated using this system. MCM-BP with no tags was generated
from pfastBacHT.MCM-BP by digesting this plasmid with Rsr II
and Nco I (which excises the 6-His tag), filling in the ends with
DNA polymerase I Klenow fragment (NEB) and religating.
StrepII-MCM-BP was generated by inserting a synthetic cassette
4 mg. Note that BSA co-migrates with MCM-BP in SDS-PAGE. Phosphorylation reactions were also performed with 4.0 mg MCM-BP alone (lane 2, left
panel) and 0.5 mg MCM2 alone (lane 1, right panel). Control reactions lacking DDK were also performed to show that labeling was due to DDK activity
(lanes 1 and 3, left panel and lane 2, right panel). B. Reactions were performed as in A except that 0.5 mg MCM2 was used in place of MCM4,6,7. C.
Quantification of
32P-labelled bands corresponding to MCM2 (from B) or MCM4 and 6 (from A) or MCM7 (from A) are shown where #1 and #2
indicates the results from A left panel and right panel, respectively. Values are shown relative to labeling in the absence of MCM-BP (set as 100%). D.
2 mg of MCM4,6,7 or MCM2-7 complex was incubated with or without 2 mg of MCM-BP, then kinase assays were performed with 250 ng of DDK or no
DDK as in A. E.
32P in the MCM2 or MCM3-7 bands in D was quantified and background labeling from reactions without DDK was subtracted from the
same reactions with DDK. The percentage of DDK-specific
32P incorporation in the presence of MCM-BP is shown relative to that in the absence of
MCM-BP.
doi:10.1371/journal.pone.0035931.g007
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pfastBacHT. MCM-BP. A baculovirus expressing Dbf4 with an N-
terminal 6-His tag followed by a triple FLAG tag was generated
using the pfastBacHT system as described for MCM7 and MCM5
in Sakwe et al [21].
Assay of MCM-BP Interactions with Individual MCM or
Dbf4 Proteins in Insect Cells
High Five insect cells were coinfected with baculoviruses
expressing MCM-BP and individual affinity-tagged MCM or
Dbf4 proteins. Where indicated, the tagged MCM proteins were
also expressed on their own (using twice as much baculovirus as in
co-infections to keep the total amount of baculovirus constant). In
Figure 3C, hexahistidine-tagged MCM-BP was co-expressed with
untagged MCM proteins. After 3 days, cells were harvested,
washed twice with PBS and lysed in 50–100 mM Tris-HCl,
pH 8.0, 150 mM NaCl, 5% glycerol, 0.5% TritonX-100,
complete protease inhibitor mixture (P8340 from Sigma), and
2 mM EDTA (omitted in experiments using Ni-NTA resin). The
lysates were clarified by centrifugation at 13,0006g for 15 minutes
then the soluble fractions were incubated with Ni-NTA (Qiagen),
anti-FLAG M2 (Sigma), anti-HA (Santa Cruz) or StrepT-actin
(Qiagen) resin (depending on the tag on the protein of interest) for
1h ra t4 uC with mixing. In Figure 3A–C, the NaCl concentration
of the clarified lysate was increased as indicated or deoxycholate
was added to 0.1 or 0.5% prior to incubation with the resin. The
resin was then washed three times for 2 minutes each with 40
volumes of Buffer A (50 mM Tris-HCl, pH 8.0, 300 mM NaCl
and 5% glycerol) and eluted with Buffer A containing 250 mM
imidazole (for Ni-NTA), 0.5 mg/ml 3-FLAG peptide (for anti-
FLAG M2; Sigma), 1% SDS (for anti-HA) or 5 mM destiobiotin
(for StrepT-actin). In Figure 3D, hexahistidine-tagged MCM4 or
MCM7 was co-expressed with untagged MCM-BP then cells were
lysed and incubated with nickel resin as above (150 mM NaCl
condition). The resin was then washed with Buffer A then
incubated with 3 volumes Buffer A containing either 0, 0.1% or
0.2% CHAPS (Sigma) for 30 min at room temperature. The
eluted proteins were then analyzed by SDS-PAGE and Coomassie
staining, Western blotting or glycerol gradient centrifugation.
Glycerol Gradient Analysis of MCM-BP-MCM Dimer Pairs
Dimer pairs of MCM-BP with an MCM protein were isolated
as described above and 150–200 mg was applied to a 12 ml 15–
35% glycerol gradient in 20 mM Tris-HCl, pH 7.5, 100 mM
NaCl, 0.1 mM EDTA, 0.1 mM PMSF, and 2 mM DTT. After
centrifugation at 34, 000 rpm in a SW41 rotor (Beckman) for
16 hours at 4uC, 24 500 ml fractions were collected from the top of
the gradient and 35 ml of each fraction was analyzed by SDS-
PAGE and silver staining.
Glycerol Gradient Analysis of MCM Proteins and MCM-BP
in HeLa Cell Lysates
HeLa cells (purchased from ATCC) were either collected in log
phase or were synchronized at G1/S by double thymidine block.
To synchronize the cells, thymidine (Sigma) was added to final
concentration of 2 mM for 19 hours, followed by two washes in
PBS and release into complete DMEM for 10 hours. Thymidine
was then added again to 2 mM for 17 hours and cells were
released into complete medium for 2, 4 or 6 hours. HeLa cells
were collected by scraping, washed twice with PBS and lysed in
five volumes of 50 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.1%
Triton X-100 (v/v), 2 mM EDTA pH 8.0, 5% glycerol (v/v) and
complete protease inhibitor (Sigma p8340). The lysate was
sonicated for 5 seconds at 50% amplitude and clarified by
centrifugation at 16,0006g for 10 minutes. Two mg of lysate
was then loaded onto a 12 ml 15–35% glycerol gradient in 25 mM
Tris-HCl pH 7.5, 100 mM NaCl, 0.1 mM EDTA pH 8.0, and
2 mM DTT. Where indicated, 30 mg of His-MCM-BP purified
from insect cells as previously described [21] was added to 2 mg of
lysate and incubated for 30 min at 4uC prior to loading on the
gradient. Glycerol gradients were subjected to centrifugation at
34,000 rpm in a Beckman SW-41 rotor for 23 hours at 4uC, then
24 500 ml fractions were collected from the top of the gradient. A
35 ml sample of each fraction was analyzed by SDS-PAGE and
Western blotting. DNA content analysis was also performed on
samples of the cells to verify cell cycle stages. To this end, cells
were fixed in 70% ethanol overnight at 220uC, washed with PBS
with 0.5% BSA, treated with 100 mg/ml RNase A for 1 hour at
37uC and stained with 50 mg/ml propidium iodide. Samples were
analyzed at the University of Toronto, Faculty of Medicine Flow
Cytometry Facility, using a FACS Calibur flow cytometer (BD
Biosciences) and data was collected using CellQuest software. Cell
cycle analysis was performed using FlowJo software (Treestar Inc.).
For the 6 hour time point, MCM-BP was immunoprecipitated
overnight with anti-MCM-BP rabbit serum from 200 ml of fraction
14 and 15 diluted with 400 ml of Buffer B (50 mM Tris, pH 8.0,
150 mM NaCl). Following by a 2 hour- incubation with protein
A/G plus beads (Santa Cruz 2003) and three washes with Buffer
B, bound proteins were eluted in SDS sample buffer and analyzed
by Western blotting.
Purification of MCM2, MCM4,6,7, MCM2-7 and MCM-BP
for DDK Assays
MCM2 and the MCM4,6,7 and MCM2-7 complexes were
purified from High Five insect cells as previously described [21].
MCM-BP was expressed in E.coli from pET15b in which the
MCM-BP cDNA was inserted between the NdeI and BamHI
restriction sites. BL21DE3 cells [51] were transformed with
pET15b.MCM-BP and expression of MCM-BP was induced for
18 hrs at 15uC by the addition of 1 mM IPTG. The bacteria were
lysed in 25 mM HEPES, pH 7.8, 500 mM NaCl, 5 mM
imidazole, 10 mM mercaptoethanol, 0.2% TritonX-100, 0.2%
CHAPS, 5% glycerol, and complete protease inhibitor mixture
(Sigma P8340) and clarified by centrifugation in a Sorvall SS-34
rotor at 13000 rpm for 30 minute. The clarified lysate was loaded
onto a Ni-NTA column (Qiagen), washed with 10 mM imidazole,
and eluted with 250 mM imidazole in lysis buffer. The His-tag was
then removed from MCM-BP by adding thrombin (1% w/w) and
dialysing overnight against 25 mM HEPES, pH 7.5, 150 mM
NaCl, 2.5 mM CaCl2, 5% glycerol, 10 mM mercaptoethanol.
MCM-BP lacking the His-tag was separated from the His tag by
flowing through a second Ni-NTA column. The MCM-BP was
then applied to a Superdex 200 gel filtration column in 20 mM
HEPES pH 7.8, 200 mM NaCl, 5 mM DTT. Peak fractions were
collected and concentrated with an Amicon Ultra centrifugal filter
devices (Millipore).
DDK Purification
pET-30a expressing both Myc-Cdc7 and 6His-Dbf4 was a gift
from Drs. Jerard Hurwitz and Joon-Kye Lee and was previously
described [31]. This plasmid was used to transform BL21(DE3)
CodonPlus – RIL cells (Novagen) and protein expression was
induced by IPTG addition for 18 hours at 15uC. The cells were
lysed in 50 mM Tris-HCl, pH 8.0, 200 mM NaCl, 5% glycerol,
10 mM imidazole and complete protease inhibitor mixture and
clarified by centrifugation in a Sorvall SS-34 rotor at 13000 rpm
for 30 minute. The clarified lysate was loaded onto a Ni-NTA
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buffer containing 250 mM imidazole and dialyzed overnight
against 25 mM Tris-HCl, pH 8.0, 150 mM NaCl, 5% glycerol,
1 mM DTT and 0.1 mM EDTA.
DDK in vitro Phosphorylation Assays
Purified MCM4,6,7 complex (2 mg), MCM2-7 complex (2 mg)
or MCM2 (0.5 mg) was incubated with 0.5, 1.0, 2.0 or 4.0 mg
purified MCM-BP or no MCM-BP for 15 minutes on ice in a 8 ml
volume, then combined with 250 ng purified DDK in a 20 ml final
volume containing 25 mM HEPES, pH 7.5, 10 mM magnesium
acetate, 0.1 mg/ml BSA, 1 mM DTT, 50 mM NaCl, 50 mM
ATP, 0.1 ml of 3000 ci/mmol [c-32-P]ATP (NEG 502A
PerkinElmer) and complete phosphatase inhibitor cocktail
(Thermo Scientific). After 30 min at 30uC, the reaction was
stopped by heating at 95uC for 3 minutes in SDS loading buffer.
Proteins were separated by 8% SDS-PAGE.
32P-labelled bands
were imaged with a Typhoon Laser Scanner (GE HealthCare life
Sciences) and quantified using ImageQuant. The positions of
individual proteins were visualized by Coomassie staining.
Yeast 2-hybrid Assays
MCM-BP was PCR amplified from pMZI.MCMBP [21] and
this cDNA was used to replace the EBNA1 cDNA in pLexA-
EBNA1 (described in [52]). Specifically, EBNA1 cDNA was
excised from pLexA-EBNA1 with Nde I and Bgl II and the MCM-
BP cDNA was inserted between these sites. MCM4 was PCR
amplified from MCM4 in pOTB7 (purchased from ResGen;
Invitrogen) and cloned between the Nco I and Bam HI sites of
pACTII. MCM7 was amplified from pMZI.MCM7 [21] and
inserted in the Xma I site of pACTII. Dbf4 in pBluescriptR and
Plk1 in pOTB1 were obtained from The Centre for Applied
Genomics (TCAG), The Hospital for Sick Children, Toronto and
used to PCR amplify the cDNA. The amplified Dbf4 or Plk1
cDNAs were inserted between the Sfi I and Eco RI sites of
pACTII. Two-hybrid assays were performed as described in
Nayyar et al [53]. Briefly, S. cerevisiae strain L40a (MATa trp1 leu2
his3 LYS2::lexA-HIS3 URA3::lexA-lacZ) [54] was transformed with
pLexA.MCMBP and with pACTII expressing the indicated
protein (fused to the GAL4 activation domain) or with empty
pACTII (negative control). Yeast were grown overnight in
medium selective for both plasmids (lacking Trp and Leu) and
10-fold serial dilutions of the cultures were spotted and grown on
plates lacking Trp and Leu or lacking Trp, Leu and His and
containing 2 mM aminotriazole (to select for yeast expressing
histidine and reduce background levels of histidine).
Immunoprecipitations from Human Cells
4610
6 HeLa cells were harvested by trypsinization and lysed in
50 mM Tris HCl pH 8, 150 mM NaCl, 5% glycerol, 5 mM
EDTA and 0.1% Triton X-100 for 30 minutes on ice. The lysate
was clarified by centrifugation at 15,000 rpm for 10 minutes.
1 mg of lysate was incubated overnight at 4uC with either MCM-
BP antibody or control IgG (Santa Cruz 2345). Subsequently,
30 ml Protein A/G agarose beads (Santa Cruz 2003) was added
and incubated for 2 hours at 4uC, then the beads were washed
three times in the lysis buffer. Immunoprecipitated proteins were
eluted from the beads in SDS sample buffer and analysed by
Western blotted using antibodies against MCM2, MCM4, MCM-
BP and Dbf4.
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